A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer

被引：0
|
作者：
Takaaki Arigami
Daisuke Matsushita
Keishi Okubo
Masataka Shimonosono
Ken Sasaki
Yusuke Tsuruda
Yoshiaki Kita
Kan Tanabe
Shinichiro Mori
Shigehiro Yanagita
Yoshikazu Uenosono
Akihiro Nakajo
Hiroshi Kurahara
Takao Ohtsuka
机构：
[1] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Onco
[2] Kagoshima University Graduate School of Medical and Dental Sciences,Biological Surgery
来源：
Surgery Today | 2022年 / 52卷
关键词：
Gastric cancer; Conversion surgery; Prognosis; Trastuzumab; HER2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1721 / 1730
页数：9
相关论文
共 50 条
  • [21] Factors Influencing Adjuvant Chemotherapy and Trastuzumab Choice in Older Human Epidermal Growth Factor Receptor 2-positive Breast Cancer Patients
    Fang, Yan
    Wang, Zheng
    Wu, Jiayi
    Huang, Ou
    He, Jianrong
    Zhu, Li
    Chen, Weiguo
    Li, Yafen
    Chen, Xiaosong
    Shen, Kunwei
    JOURNAL OF CANCER, 2020, 11 (09): : 2602 - 2609
  • [22] Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report
    Chen, Zhe-Ling
    Zhao, Andi
    Li, Pan
    Zhang, Mi
    Yang, Jiao
    Zhang, Lingxiao
    Zhao, Xiaoai
    Yang, Jin
    Wang, Le
    ONCOLOGY LETTERS, 2018, 16 (04) : 4614 - 4620
  • [23] Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Spector, Neil L.
    Blackwell, Kimberly L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : 5838 - 5847
  • [24] Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer
    Sotelo, Miguel J.
    Angel Garcia-Saenz, Jose
    Manso, Luis
    Moreno, Fernando
    Ciruelos, Eva
    Callata, Hector R.
    Mendiola, Cesar
    Cabezas, Santiago
    Ghanem, Ismael
    Diaz-Rubio, Eduardo
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) : 967 - 972
  • [25] MACC1 INVOLVED IN THE REGULATION OF RESISTANCE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE GASTRIC CANCER CELLS TO TRASTUZUMAB
    Zhang, Guofei
    Hu, Kefu
    Yu, Rong
    Su, Gang
    Xiong, Xin
    Hu, Daqian
    Zhang, Zhihong
    ACTA MEDICA MEDITERRANEA, 2019, 35 (05): : 2439 - 2443
  • [26] Locoregional therapy with α-emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2-positive gastric cancer in mice
    Li, Huizi Keiko
    Morokoshi, Yukie
    Nagatsu, Kotaro
    Kamada, Tadashi
    Hasegawa, Sumitaka
    CANCER SCIENCE, 2017, 108 (08): : 1648 - 1656
  • [27] Safety and Efficacy of Trastuzumab Emtansine in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: a Meta-analysis
    Shen, Kai
    Ma, Xuelei
    Zhu, Chenjing
    Wu, Xin
    Jia, Hongyuan
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Isolated CNS Relapse in Human Epidermal Growth Factor Receptor 2-Positive Esophagogastric Cancer: Effective Treatment With Trastuzumab After Failure of Surgery and Radiotherapy
    Geldart, Tom
    Astras, George
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (23) : E664 - E665
  • [29] Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer
    Hurley, J
    Doliny, P
    Reis, I
    Silva, O
    Gomez-Fernandez, C
    Velez, P
    Pauletti, G
    Pegram, MD
    Slamon, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1831 - 1838
  • [30] Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer
    Yu, Ke-Da
    Zhou, Zhi-Rui
    Shao, Zhi-Ming
    CANCER RESEARCH, 2020, 80 (04)
12345